QUARK VENTURE
Established in 2015, Quark Venture Inc. is a venture capital investment firm, headquartered in Vancouver, Canada, and is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
QUARK VENTURE
Founded:
2015-01-01
Status:
Active
Contact:
604-262-8818
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Google Maps PHP
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Karimah Es Sabar Chief Executive Officer & Partner @ Quark Venture
Chief Executive Officer & Partner
2016-09-21
Jesson Chen Co-Founder, Chairman & Partner @ Quark Venture
Co-Founder, Chairman & Partner
Neena Kadaba Director, Science @ Quark Venture
Director, Science
2017-01-01
Zafrira Avnur Chief Scientific Officer @ Quark Venture
Chief Scientific Officer
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-24 | Lyndra Therapeutics | Quark Venture investment in Series C - Lyndra Therapeutics | 60.5 M USD |
| 2021-04-06 | Volastra Therapeutics | Quark Venture investment in Seed Round - Volastra Therapeutics | 32 M USD |
| 2021-03-11 | CalciMedica | Quark Venture investment in Series D - CalciMedica | 21 M USD |
| 2020-09-22 | V-Wave | Quark Venture investment in Series C - V-Wave | 28 M USD |
| 2020-02-19 | EnClear Therapies | Quark Venture investment in Series A - EnClear Therapies | 10 M USD |
| 2020-02-11 | Volastra Therapeutics | Quark Venture investment in Seed Round - Volastra Therapeutics | 12 M USD |
| 2020-01-08 | Eyevensys | Quark Venture investment in Series B - Eyevensys | 30 M USD |
| 2019-12-18 | Raziel Health | Quark Venture investment in Series C - Raziel Health | 22 M USD |
| 2019-12-03 | Raziel Therapeutics | Quark Venture investment in Series C - Raziel Therapeutics | 2 M USD |
| 2019-05-29 | Pi Therapeutics | Quark Venture investment in Series B - Pi Therapeutics | 19.7 M USD |
More informations about "Quark Venture"
Profile - Quark Venture
Quark Venture LP is led by a unique senior management team and supported by a scientific and commercial advisory board. Quark Venture LP ’s senior management team has both broad …See details»
Our Team - Quark Venture
Quark Venture is led by a unique senior management team and supported by key leading international scientific and commercial advisors Mr. Jesson Chen Chairman & General PartnerSee details»
Quark Venture - Crunchbase Investor Profile
Non-Management, Executive Management, Operations 3 emails found . View contacts for Quark Venture to access new leads and connect with decision-makers. View All Contacts . ... Established in 2015, Quark Venture Inc. is a …See details»
CVCA Member Profile: Quark Venture | CVCA Central
Oct 26, 2022 Through a joint venture with a leading investment bank, Quark Venture established the Global Health Sciences (GHS) Fund in 2016, giving Quark the financial firepower needed to invest globally. Quark Venture is …See details»
Quark Venture - Investments, Portfolio & Company Exits
Quark Venture 's most notable exits include Keros Therapeutics, CalciMedica, and V-Wave. Which industries has this organization had the most exits in? Show . Keros Therapeutics …See details»
Quark Venture - LinkedIn
Quark Venture | 311 abonnés sur LinkedIn. Established in 2016, Quark Venture is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough …See details»
Top 50 Venture Capital Firms in Canada in 2024 - Failory
Pangaea Ventures is a VC organization that invests in advanced materials to solve the world’s most fundamental challenges. Details of the VC firm: Country: Canada, USA ... Quark Venture. Founded in 2016, Quark Venture is a …See details»
Karimah Es Sabar - HSO Health Standards Organization
Prior to joining Quark Venture, Mrs. Es Sabar was CEO & President of the Centre for Drug Research and Development (CDRD), and CEO & President of LifeSciences BC, and she has …See details»
Quark Venture sets up $656 million technology fund
Oct 17, 2016 Vancouver-based venture capital firm Quark Venture said Monday it is setting up a US$500-million ($656 million) biotechnology fund — “the largest of its kind in Canada,” as …See details»
Vancouver-Based MSI Raises US$30 Million Investment from …
Oct 6, 2016 Today, Quark Venture Inc., a venture capital company, announced a US$30 million investment in MSI , a clinical-stage pharmaceutical company, that will enable MSI to advance …See details»
Ms. Karimah Es Sabar - Quark Venture
Quark Venture LP. A highly-recognized Canadian life sciences leader with broad international experience, Karimah Es Sabar has had a successful career spanning the global …See details»
Telix Pharmaceuticals Limited Completes the Acquisition of …
Apr 11, 2024 In 2017, ARTMS Inc. was formed with support and seed funding from Quark Venture, through their Global Health Sciences Fund (GHS) and founding institutions TRIUMF, …See details»
Quark Venture, with help from China, sets up $500M life sciences …
Oct 18, 2016 Investment co Quark Venture and China’s GF Securities are setting up a global $500 million life sciences fund in what the pair are describing as the largest of its kind in the …See details»
New US$500m biotech venture fund to be based in Vancouver
Oct 18, 2016 The fund being set up by Quark Venture Inc. and GF Securities Company Limited will be based in Vancouver and will be the largest of its kind in Canada, the companies said in …See details»
QUARK VENTURES, LLC | Florida Company Directory
QUARK VENTURES, LLC was filed on 03 Jan 2012 as Limited Liability Company type, registered at 6501 CONGRESS AVE STE 300 BOCA RATON, FL 33487 . It's Document Number is …See details»
Dr. Zafrira Avnur - Quark Venture
In October 2016 Ms. Avnur Joined Quark Venture LP as Chief Scientific Officer and General Partner, a venture investment fund focused on life sciences investments. Quark Venture LP is …See details»
Quark Venture_投资机构 - 企查查
企查查为您提供Quark Venture投资机构详情查询，包括Quark Venture介绍、投资风格、投资项目、投资事件、投资团队以及Quark Venture最新投资动态等信息。 全国企业信用查询系统 官方 …See details»
Anthropic raises Series E at $61.5B post-money valuation
Mar 3, 2025 Anthropic has raised $3.5 billion at a $61.5 billion post-money valuation. The round was led by Lightspeed Venture Partners, with participation from Bessemer Venture Partners, …See details»
Xiao Yu - Quark Venture
Mr. Xiao Yu is currently the Director Investment & Principal of Global Health Science Fund (GHSF), a joint venture health science fund of which Quark Venture is the general partner of. …See details»
Al Gore Venture Gets Investment From Calstrs, Microsoft - Yahoo …
4 days ago (Bloomberg) -- A venture started by Al Gore’s Generation Investment Management has raised $175 million to invest in businesses that enable the restoration of land degraded by …See details»